Company Filing History:
Years Active: 2016-2024
Title: The Innovative Contributions of Li Zhang in Antibody Therapeutics
Introduction
Li Zhang, an accomplished inventor based in Baldwin Place, NY, has made significant strides in the field of biotechnology with her innovative work. With a total of two patents to her name, her contributions, particularly in the realm of antibody therapeutics, exemplify her commitment to advancing medical science.
Latest Patents
Li Zhang’s latest patents include groundbreaking developments such as Anti-FGFR2 antibodies and methods of use thereof. This patent outlines monoclonal antibodies and antigen-binding fragments that specifically bind to fibroblast growth factor receptor 2 (FGFR2). The invention also focuses on antibody-drug conjugates (ADCs) that link the anti-FGFR2 antibodies or fragments to cytotoxic agents or radionuclides, paving the way for effective methods of treatment.
Her second patent discusses methods of inhibiting tumor growth by antagonizing the IL-6 receptor. This innovative approach provides methods for reducing tumor growth in subjects by administering an IL-6 antagonist, which may be an antibody specifically targeting IL-6R. These methods are particularly useful in treating anti-VEGF-resistant tumors, potentially in combination with VEGF or EGFR antagonists.
Career Highlights
Li Zhang currently works at Regeneron Pharmaceuticals, Inc., a leading biopharmaceutical company that focuses on developing innovative therapies for serious medical conditions. Her role in research and development showcases her expertise and ability to contribute to cutting-edge advancements in the pharmaceutical industry. Li's dedication to her work has led her to explore novel therapeutic strategies that can significantly impact patient treatment outcomes.
Collaborations
Throughout her career, Li has collaborated with notable coworkers, including Christopher Daly and Frank Delfino. These professional relationships have enabled her to pool knowledge and resources, fostering an environment conducive to innovation and development in the field of antibody therapeutics.
Conclusion
Li Zhang’s inventive contributions to the field of biotechnology, particularly through her patented work on antibody therapeutics, reflect her dedication to scientific advancement. Her ongoing research at Regeneron Pharmaceuticals, Inc. continues to push the boundaries of what is possible in treating complex diseases, demonstrating the vital role of inventors in transforming healthcare.